As of 2024-12-14, the EV/EBITDA ratio of Kuros Biosciences AG (KURN.SW) is -117.02. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KURN.SW's latest enterprise value is 772.95 mil CHF. KURN.SW's TTM EBITDA according to its financial statements is -6.61 mil CHF. Dividing these 2 quantities gives us the above KURN.SW EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |
| 2024-12-11 | -122.17 |
| 2024-12-10 | -116.17 |
| 2024-12-09 | -113.60 |
| 2024-12-06 | -110.63 |
| 2024-12-05 | -111.77 |
| 2024-12-04 | -110.51 |
| 2024-12-03 | -113.03 |
| 2024-12-02 | -117.88 |
| 2024-11-29 | -125.59 |
| 2024-11-28 | -124.45 |
| 2024-11-27 | -128.17 |
| 2024-11-26 | -131.31 |
| 2024-11-25 | -133.02 |
| 2024-11-22 | -137.59 |
| 2024-11-21 | -126.74 |
| 2024-11-20 | -137.88 |
| 2024-11-19 | -128.17 |
| 2024-11-18 | -113.31 |
| 2024-11-15 | -141.31 |
| 2024-11-14 | -177.30 |
| 2024-11-13 | -165.59 |
| 2024-11-12 | -160.16 |
| 2024-11-11 | -163.01 |
| 2024-11-08 | -157.59 |
| 2024-11-07 | -161.02 |
| 2024-11-06 | -155.87 |
| 2024-11-05 | -158.16 |
| 2024-11-04 | -154.73 |
| 2024-11-01 | -153.02 |
| 2024-10-31 | -141.31 |
| 2024-10-30 | -145.02 |
| 2024-10-29 | -145.88 |
| 2024-10-28 | -139.88 |
| 2024-10-25 | -137.31 |
| 2024-10-24 | -139.88 |
| 2024-10-23 | -145.59 |
| 2024-10-22 | -138.16 |
| 2024-10-21 | -135.88 |
| 2024-10-18 | -134.16 |
| 2024-10-17 | -137.02 |
| 2024-10-16 | -131.88 |
| 2024-10-15 | -130.16 |
| 2024-10-14 | -127.31 |
| 2024-10-11 | -112.00 |
| 2024-10-10 | -102.28 |
| 2024-10-09 | -108.45 |
| 2024-10-08 | -107.88 |
| 2024-10-07 | -109.14 |
| 2024-10-04 | -105.03 |
| 2024-10-03 | -98.86 |